Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
The Pediatric Infectious Disease Journal|November 3, 2010
Adverse Events Following Trivalent Inactivated Influenza Vaccination in Children: Analysis of the Vaccine Adverse Event Reporting SystemRiyadh Muhammad, Penina Haber, Karen Broder, et al.Early Human Development|May 14, 2015
Safety of octreotide in hospitalized infantsDaniela Testoni, Christoph P Hornik, Megan L Neely, et al.Pediatrics|October 8, 2014
Adherence to guidelines for glucose assessment in starting second-generation antipsychoticsMarsha A Raebel, Robert Penfold, Ann W McMahon, et al.Pharmacoepidemiology and Drug Safety|July 28, 2010
Description of hypersensitivity adverse events following administration of heparin that was potentially contaminated with oversulfated chondroitin sulfate in early 2008Ann W McMahon, Robert G Pratt, Tarek A Hammad, et al.Drugs - Real World Outcomes|March 1, 2020
Real-World Evidence to Assess Medication Safety or Effectiveness in Children: Systematic ReviewTamar Lasky, Bruce Carleton, Daniel B Horton, et al.Vaccine|January 24, 2007
Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 casesAnn W McMahon, Rachel B Eidex, Anthony A Marfin, et al.Paediatric Drugs|November 29, 2018
Serious Adverse Events Associated with Off-Label Use of Azithromycin or Fentanyl in Children in Intensive Care Units: A Retrospective Chart ReviewKazeem A Oshikoya, Gerold T Wharton, Debbie Avant, et al.Pharmacoepidemiology and Drug Safety|September 10, 2023
Overview of global real-world data sources for pediatric pharmacoepidemiologic researchGerold T Wharton, Claudia Becker, Dimitri Bennett, et al.Pediatrics|January 16, 2020
Big Data in the Assessment of Pediatric Medication SafetyAnn W McMahon, William O Cooper, Jeffrey S Brown, et al.American Heart Journal|October 17, 2012
Pediatric cardiovascular safety: challenges in drug and device development and clinical applicationKatherine E Bates, Victoria L Vetter, Jennifer S Li, et al.Pageof 3